A Study of LY4064809 [14C]-STX-478 in Healthy Male Participants

NCT06901336 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company